Description
Product details
HPDOL DEPOT 50 & Hpdol Injection Generic Name: Haloperidol Description HPDOL DEPOT 50 contains Haloperidol Decanoate, a long-acting depot antipsychotic formulation. It is generally used for maintenance treatment of certain psychotic disorders, particularly in patients who require long-term haloperidol therapy. Hpdol Injection contains Haloperidol Injection IP, a shorter-acting injectable formulation used in selected clinical situations where injectable antipsychotic treatment is required. Haloperidol is a first-generation antipsychotic belonging to the butyrophenone class. It acts primarily by blocking dopamine D2 receptors in the central nervous system, helping control symptoms such as hallucinations, delusions, severe agitation, and disorganized thinking. Available Forms Product Active Ingredient Dosage Form HPDOL DEPOT 50 Haloperidol Decanoate Long-acting depot injection Hpdol Injection Haloperidol Injection IP Injection The exact concentration and volume of each presentation should be confirmed from the individual product label. Dosage The dose must be determined by a qualified healthcare professional according to: Patient's diagnosis and severity of symptoms Previous response to haloperidol Current oral antipsychotic treatment Age and general medical condition Other medicines being used Risk of adverse effects HPDOL DEPOT 50 is a long-acting formulation and is administered at intervals determined by the treating physician. Hpdol Injection should be administered by a healthcare professional according to its approved route and product instructions. The two formulations are not interchangeable on a dose-for-dose basis. Precautions Inform the doctor about heart disease, abnormal heart rhythm, Parkinson's disease, seizures, or liver problems. Electrolyte abnormalities may increase the risk of cardiac rhythm problems. Tell the healthcare professional about all other medicines being used. Monitor for tremor, stiffness, restlessness, or abnormal involuntary movements. Long-term treatment may result in tardive dyskinesia. Alcohol and other CNS depressants may worsen sedation and related adverse effects. Pregnancy and breastfeeding require medical assessment. Extra caution is necessary in elderly patients. Side Effects Possible side effects include: Drowsiness Dizziness Restlessness Muscle stiffness Tremor Abnormal movements Headache Dry mouth Constipation Changes in blood pressure Injection-site reactions Serious adverse effects can include tardive dyskinesia, significant cardiac rhythm abnormalities, severe extrapyramidal reactions, and neuroleptic malignant syndrome (NMS). Warning HPDOL DEPOT 50 and Hpdol Injection should be administered only under appropriate medical supervision. Haloperidol may cause QT prolongation and serious cardiac arrhythmias, particularly in susceptible patients or with inappropriate exposure. A rare but potentially life-threatening condition called Neuroleptic Malignant Syndrome (NMS) may occur. High fever, severe muscle rigidity, altered consciousness, or autonomic instability require immediate medical attention. FAQ 1. What is HPDOL DEPOT 50? It is a long-acting Haloperidol Decanoate injection used for maintenance antipsychotic treatment in appropriate patients. 2. What does Hpdol Injection contain? It contains Haloperidol Injection IP. 3. What is the difference between HPDOL DEPOT and Hpdol Injection? HPDOL DEPOT contains Haloperidol Decanoate and provides prolonged drug release, while Hpdol Injection is a shorter-acting haloperidol formulation. 4. How does Haloperidol work? It primarily blocks dopamine D2 receptors in the brain, helping control certain psychotic symptoms. 5. Can these two injections be used interchangeably? No. Depot haloperidol decanoate and shorter-acting haloperidol injection have different pharmacokinetic profiles and should not be considered dose-for-dose interchangeable. 6. What serious side effects require medical attention? High fever with severe muscle stiffness, abnormal heart rhythm symptoms, severe movement disorders, or serious allergic reactions require prompt medical evaluation.
